Phytotherapy

DRUG2 trials

Sponsors

Pierre Fabre Medicament, Klaipėda University

Conditions

Benign Prostatic HyperplasiaParticipation Level Below 55% and/or Special Needs

Unknown Phase

A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic Hyperplasia

CompletedNCT07144709

Pierre Fabre MedicamentBenign Prostatic Hyperplasia

Start: 2022-06-22End: 2024-07-29Updated: 2025-08-27

Effects of Hirudotherapy, Phytotherapy, and Forest Therapy in Adults With Reduced Work Capacity or Special Needs

Active, not recruitingNCT07709221

Klaipėda UniversityParticipation Level Below 55% and/or Special Needs

Start: 2026-04-15End: 2026-12-20Target: 100Updated: 2026-07-16